Farther Finance Advisors’s Day One Biopharmaceuticals DAWN Stock Holding History

Farther Finance Advisors’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-216	Closed	-$4.63K	–	6014
2026 Q1	$4.63K	Buy	216 +156	+260%	+$2.2K	﹤0.01%	4539
2025 Q4	$559	Sell	60 -12	-17%	-$100	﹤0.01%	5034
2025 Q3	$508	Buy	72 +25	+53%	+$172	﹤0.01%	4538
2025 Q2	$306	Buy	47 +46	+4,600%	+$316	﹤0.01%	4133
2025 Q1	$8	Sell	1 -6	-86%	-$65	﹤0.01%	4227
2024 Q4	$89	Hold	7	–	–	﹤0.01%	3801
2024 Q3	$98	Buy	7 +6	+600%	+$86	﹤0.01%	3782
2024 Q2	$14	Hold	1	–	–	﹤0.01%	3768
2024 Q1	$16	Sell	1 -2	-67%	-$30	﹤0.01%	3542
2023 Q4	$44	Buy	+3	New	+$36	﹤0.01%	3396

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Farther Finance Advisors's DAWN Position: Q2 2026 in Review

Farther Finance Advisors sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 216 shares — an estimated $4.63K sold.

Farther Finance Advisors first reported a position in DAWN in Q4 2023 and held it in 10 quarters. The position peaked at $4.63K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Farther Finance Advisors reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Farther Finance Advisors sold 216 Day One Biopharmaceuticals shares in Q2 2026, an estimated $4.63K.
Farther Finance Advisors first reported a position in Day One Biopharmaceuticals in Q4 2023 and held it in 10 quarters.
Farther Finance Advisors's Day One Biopharmaceuticals position peaked at $4.63K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.